HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lisa Pieri Selected Research

ruxolitinib

10/2017Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results.
2/2017Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms.
5/2015JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib.
1/2015Ruxolitinib-induced reversal of alopecia universalis in a patient with essential thrombocythemia.
4/2014Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.
3/2014Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.
2/2014A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lisa Pieri Research Topics

Disease

10Polycythemia Vera
02/2017 - 11/2009
9Primary Myelofibrosis (Myelosclerosis)
02/2017 - 08/2011
8Neoplasms (Cancer)
01/2018 - 04/2003
8Essential Thrombocythemia
10/2017 - 01/2008
5Hemorrhage
09/2020 - 03/2008
4Thrombosis (Thrombus)
02/2017 - 02/2009
3Splenomegaly
02/2017 - 04/2014
2Hemophilia A (Haemophilia)
09/2020 - 09/2018
2Disease Progression
08/2014 - 07/2011
2Fibrosis (Cirrhosis)
04/2014 - 03/2012
2Melanoma (Melanoma, Malignant)
07/2003 - 04/2003
1Metabolic Bone Diseases (Osteopenia)
09/2020
1Mastocytosis
11/2018
1Systemic Mastocytosis
11/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2018
1Alopecia universalis
01/2015
1Leukemia
10/2014
1Anemia
04/2014
1Thrombocytopenia (Thrombopenia)
04/2014
1Fatigue
04/2014
1Hyperplasia
04/2014
1Pruritus (Itching)
02/2014
1Pain (Aches)
02/2014
1Philadelphia Chromosome
05/2012
1Leukocytosis (Pleocytosis)
05/2012
1Thrombocytosis (Thrombocythemia)
08/2011
1Heart Failure
07/2010
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
07/2010
1Acute Coronary Syndrome
03/2008
1Venous Thromboembolism
03/2008
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2008
1Neoplasm Metastasis (Metastasis)
07/2003
1Carcinogenesis
04/2003

Drug/Important Bio-Agent (IBA)

7ruxolitinibIBA
10/2017 - 02/2014
5Hydroxyurea (Hydrea)FDA LinkGeneric
10/2017 - 08/2010
3CalreticulinIBA
10/2014 - 03/2014
3EnzymesIBA
07/2003 - 04/2003
2Vitamin KFDA Link
01/2020 - 03/2008
2Janus Kinase 2IBA
10/2014 - 07/2011
2Reticulin (Reticular Fiber)IBA
04/2014 - 03/2012
2Proteins (Proteins, Gene)FDA Link
11/2009 - 04/2003
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
07/2003 - 04/2003
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
05/2003 - 04/2003
1OsteocalcinIBA
09/2020
1Collagen Type I (Type I Collagen)IBA
09/2020
1hydroxide ionIBA
09/2020
1Alkaline PhosphataseIBA
09/2020
125-hydroxyvitamin DIBA
09/2020
1Parathyroid Hormone (Parathormone)IBA
09/2020
1Tryptases (Tryptase)IBA
11/2018
1Blood Coagulation Factors (Coagulation Factor)IBA
09/2018
1Heparin (Liquaemin)FDA LinkGeneric
11/2015
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
11/2015
1Heparitin Sulfate (Heparan Sulfate)IBA
11/2015
1GlycosaminoglycansIBA
11/2015
1CytokinesIBA
11/2015
1TetraspaninsIBA
06/2015
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2015
1IsotopesIBA
04/2014
1ErythropoietinFDA Link
04/2014
1Hemoglobins (Hemoglobin)IBA
01/2014
1EverolimusFDA Link
08/2011
1Biomarkers (Surrogate Marker)IBA
02/2011
1Imatinib Mesylate (Gleevec)FDA Link
07/2010
1Messenger RNA (mRNA)IBA
11/2009
1Interleukin-3 (Interleukin 3)IBA
11/2009
1AnticoagulantsIBA
03/2008
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
03/2008
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2008
1Superoxides (Superoxide)IBA
07/2003
1Transcription Factors (Transcription Factor)IBA
07/2003
1TransferasesIBA
07/2003
1DNA (Deoxyribonucleic Acid)IBA
07/2003
1NF-kappa B (NF-kB)IBA
07/2003
1IronIBA
05/2003
1Transferrin (beta 2 Transferrin)IBA
05/2003
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
04/2003
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2003
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2003
1Oxidants (Oxidizing Agents)IBA
04/2003
1Protein Kinases (Protein Kinase)IBA
04/2003
1Phosphotransferases (Kinase)IBA
04/2003
1A-factor (Streptomyces)IBA
04/2003

Therapy/Procedure

8Therapeutics
11/2018 - 02/2009
1Drug Therapy (Chemotherapy)
01/2018
1Platelet Transfusion (Blood Platelet Transfusions)
01/2018
1Ligation
06/2015